Kalaris Therapeutics
KLRS----
全部股東
股東類型
- 創投/私募54.11%
- 機構投資者16.19%
- 公眾及其他14.27%
- 個人與內幕人士6.02%
- 其他9.41%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Samsara BioCapital LLC | 54.11% | 1,288.12 萬 | 2.20% | -6.69 萬 | 30/06/2026 |
RTW Investments, LP | 5.46% | 130.00 萬 | 0.19% | +0 | 30/06/2026 |
ElevateBio, LLC | 3.05% | 72.50 萬 | 0.11% | +0 | |
Alyeska Investment Group, L.P. | 2.41% | 57.27 萬 | 0.09% | +0 | 30/06/2026 |
Samir PatelFormer Director & Co-Founder | 2.22% | 52.83 萬 | 0.08% | +0 | 18/03/2025 |
Napoleone FerraraIndependent Director & Co-Founder | 2.12% | 50.40 萬 | 0.07% | +0 | |
Vanguard Capital Management, LLC | 1.95% | 46.49 萬 | 0.68% | +17.28 萬 | 30/06/2026 |
Artal Group S.A. | 1.83% | 43.58 萬 | 0.06% | +0 | 30/06/2026 |
Ikarian Capital, LLC | 1.51% | 36.00 萬 | 0.05% | +0 | 30/06/2026 |
UBS Asset Management AG | 1.10% | 26.21 萬 | 1.07% | +25.59 萬 | 30/06/2026 |
Morana Jovan-EmbiricosFormer Independent Director | 0.91% | 21.57 萬 | 0.03% | +0 | |
Renaissance Technologies LLC | 0.63% | 14.94 萬 | 0.34% | +8.32 萬 | 30/06/2026 |
Marshall Wace LLP | 0.58% | 13.92 萬 | 0.29% | +7.13 萬 | 30/06/2026 |
David HallalIndependent Chairman of the Board | 0.55% | 13.06 萬 | 0.02% | +0 | |
Globeways Holdings II Limited | 0.53% | 12.64 萬 | 0.02% | +0 | |
Geode Capital Management, LLC | 0.48% | 11.40 萬 | 0.10% | +2.65 萬 | 30/06/2026 |
Woodline Partners LP | 0.42% | 10.00 萬 | 0.01% | +0 | 30/06/2026 |
ADAR1 Capital Management, LLC | 0.42% | 10.00 萬 | 0.01% | +0 | 30/06/2026 |
Whi Trust Co Llc | 0.41% | 9.75 萬 | 0.01% | +0 | 30/06/2026 |
Raymond James Financial, Inc. | 0.41% | 9.72 萬 | 0.11% | -2.17 萬 | 30/06/2026 |